Sanofi | SNY - PE Price to Earnings




Sanofi reported 30.71 in PE Price to Earnings for its fiscal quarter ending in September of 2024.

Pe Change Date
AbbVie 62 10.94 Sep/2024
Amgen 33.29 0.06 Dec/2024
AstraZeneca 37.64 0.94 Sep/2024
Bristol-Myers Squibb 14.05 0 Sep/2024
Corcept Therapeutics 40.96 10.02 Sep/2024
Drreddys Laboratories 19.97 0.95 Jun/2024
Eli Lilly 109.11 24.23 Sep/2024
Galapagos 53.92 4.26 Sep/2024
Genmab 19.19 1.83 Sep/2024
GlaxoSmithKline GBP 15.54 1.48 Sep/2024
Glaxosmithkline 15.65 0.04 Sep/2024
Indivior 391.99 376.82 Sep/2024
J&J 24.52 0.75 Sep/2024
Merck 20.86 116.7 Sep/2024
Novartis 17.16 6.46 Dec/2024
Novartis 23.52 0.02 Sep/2024
Pacira 11.23 7.72 Sep/2024
Perrigo 402.25 7.72K Mar/2024
Pfizer 35.67 19.94 Sep/2024
Prestige Brands 17.63 1.12 Sep/2024
Roche Holding 19.32 1.87 Jun/2024
Sanofi 30.62 5.71 Sep/2024
Sanofi 30.71 0.07 Sep/2024
Supernus Pharmaceuticals 346.44 1.36K Sep/2024
UCB 156.24 77.45 Jun/2024
Zoetis 38.31 4.91 Sep/2024